NO20085423L - stable formulation comprising moisturizing drug and method of preparation thereof - Google Patents

stable formulation comprising moisturizing drug and method of preparation thereof

Info

Publication number
NO20085423L
NO20085423L NO20085423A NO20085423A NO20085423L NO 20085423 L NO20085423 L NO 20085423L NO 20085423 A NO20085423 A NO 20085423A NO 20085423 A NO20085423 A NO 20085423A NO 20085423 L NO20085423 L NO 20085423L
Authority
NO
Norway
Prior art keywords
preparation
stable formulation
pharmaceutical
moisturizing
drug
Prior art date
Application number
NO20085423A
Other languages
Norwegian (no)
Inventor
Michael Fox
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of NO20085423L publication Critical patent/NO20085423L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Stabile farmasøytiske preparater omfattende fuktighetsfølsomme legemidler, spesielt en inhibitor av et angiotensinkonverterende enzym (ACE), så som cilazapril, som den aktive ingrediens, og minst én farmasøytisk eksipiens, hvor den aktive farmasøytiske ingrediens er våtgranulert med en oppløsning av minst én farmasøytisk eksipiens. Det beskrives også fremgangsmåter for fremstilling av slike stabile farmasøytiske preparater.Stable pharmaceutical compositions comprising moisture sensitive drugs, in particular an angiotensin converting enzyme (ACE) inhibitor, such as cilazapril, as the active ingredient, and at least one pharmaceutical excipient, wherein the active pharmaceutical ingredient is wet granulated with a solution of at least one pharmaceutical excipient. Methods are also described for the preparation of such stable pharmaceutical compositions.

NO20085423A 2006-06-02 2008-12-30 stable formulation comprising moisturizing drug and method of preparation thereof NO20085423L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/021586 WO2007142628A1 (en) 2006-06-02 2006-06-02 Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof

Publications (1)

Publication Number Publication Date
NO20085423L true NO20085423L (en) 2009-02-25

Family

ID=37607178

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20085423A NO20085423L (en) 2006-06-02 2008-12-30 stable formulation comprising moisturizing drug and method of preparation thereof

Country Status (8)

Country Link
JP (1) JP2009538905A (en)
CN (1) CN101460191A (en)
BR (1) BRPI0621739A2 (en)
CA (1) CA2652620A1 (en)
IL (1) IL195060A0 (en)
MX (1) MX2008015343A (en)
NO (1) NO20085423L (en)
WO (1) WO2007142628A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008020701A1 (en) 2008-04-24 2009-10-29 Bayer Technology Services Gmbh Formulation with reduced hygroscopicity
WO2013121233A1 (en) * 2012-02-17 2013-08-22 Egis Gyógyszergyár Nyilvánosan Működö Részvénytársaság Pharmaceutical formulation having improved stability
FR2991179B1 (en) 2012-06-01 2016-11-11 Ceva Sante Animale ORAL VETERINARY COMPOSITIONS APPENDED

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3739690A1 (en) * 1987-11-24 1989-06-08 Hoechst Ag STABILIZED MEDICINAL PRODUCTS, METHOD FOR THEIR PRODUCTION AND STABLE MEDICAL PREPARATIONS
DE19952030A1 (en) * 1999-10-28 2001-05-03 Basf Ag Process for the production of highly reactive polyisobutenes
AU2003217916A1 (en) * 2002-03-08 2003-09-22 Teva Pharmeceuticals Usa, Inc. Stable formulations of angiotensin converting enzyme (ace) inhibitors
US6869963B2 (en) * 2003-07-11 2005-03-22 Sandoz Ag Stable pharmaceutical compositions containing an ACE inhibitor
TW201240679A (en) * 2004-03-12 2012-10-16 Capsugel Belgium Nv Pharmaceutical formulations

Also Published As

Publication number Publication date
WO2007142628A1 (en) 2007-12-13
CA2652620A1 (en) 2007-12-13
MX2008015343A (en) 2008-12-16
IL195060A0 (en) 2011-08-01
JP2009538905A (en) 2009-11-12
CN101460191A (en) 2009-06-17
BRPI0621739A2 (en) 2011-12-20

Similar Documents

Publication Publication Date Title
DE602006014990D1 (en) INTRANASAL ADMINISTRATION OF FAST-ACTING INSULIN
NO20042161L (en) Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
NO20080164L (en) N- (pyridin-2-yl) -sulfonamidderivater
NO20082159L (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
NO20080827L (en) Solid dosage formulations of narcotic drugs that have improved buccal adsorption
NO20061245L (en) Pharmaceutical compositions and processes comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a bisphosphone
NO20080220L (en) Formulations with high drug loading and dosage forms
NO20081878L (en) Diacylindazole derivatives as lipase and phospholipase inhibitors
NO20081942L (en) Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
NO20042596L (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
EP1848541A4 (en) Method and device for ophthalmic administration of active pharmaceutical ingredients
DK2451445T3 (en) PROCEDURE FOR DRYING BIBW2992, IT'S SALTS AND SOLID PHARMACEUTICAL FORMULATIONS INCLUDING THIS ACTIVE INGREDIENT
NO340679B1 (en) Pyridazine derivatives, pharmaceutical compositions comprising such and such compounds and preparations for use in therapeutically active substances for the treatment and prevention of diseases
DE602005021770D1 (en) INDOLE-1-YL-ACETIC DERIVATIVES
NO20071074L (en) Substituted cyclic urea derivatives, their preparation and their pharmaceutical use as kinase inhibitors
NO20065726L (en) Compounds and compositions for delivery of active compounds.
BRPI0517792A (en) macrolones - amino substituted quinolones
NO20074933L (en) Pharmaceutical composition comprising an indolylmaleimide derivative
CY1110906T1 (en) PHARMACEUTICAL COMPOSITION FOR NON-ADMINISTRATION OF FENTANYL
CY1107819T1 (en) PHARMACEUTICAL FORM OF OLANZAPIN
WO2007090661A3 (en) Active substance combination comprising azolylcarbinol compounds
NO20061236L (en) Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and parathyroid hoziiton
BR0306928A (en) Stable pharmaceutical compositions comprising angiotensin converting enzyme inhibitors (ace)
NO20083183L (en) Solid pharmaceutical composition containing irbesartan
NO20085423L (en) stable formulation comprising moisturizing drug and method of preparation thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application